Impact of sacubitril–valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO‐SAS study design

AIMS: Sleep‐disordered breathing (SDB) is a highly prevalent co‐morbidity in patients with chronic heart failure (CHF) and can play a detrimental role in the pathophysiology course of CHF. However, the best way to manage SDB in CHF remains a matter of debate. Sacubitril–valsartan has been included i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaffuel, Dany, Molinari, Nicolas, Berdague, Philippe, Pathak, Atul, Galinier, Michel, Dupuis, Marion, Ricci, Jean‐Etienne, Mallet, Jean‐Pierre, Bourdin, Arnaud, Roubille, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Study Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933955/
https://www.ncbi.nlm.nih.gov/pubmed/29469206
http://dx.doi.org/10.1002/ehf2.12270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933955/
https://www.ncbi.nlm.nih.gov/pubmed/29469206
http://dx.doi.org/10.1002/ehf2.12270

Ejemplares similares